logo
  

Adobe Advances Data-Driven Marketing Across Mobile Devices - Quick Facts

Design software maker Adobe Systems Inc. (ADBE) Tuesday launched new data-driven marketing capabilities in Adobe Marketing Cloud, which deliver highly personalized mobile experiences.

According to the firm, Intelligent Location Marketing features enable companies to engage their customers with relevant content and messages based on a user's proximity to iBeacons.

Marketers can deliver location based "in-app" messages to drive real-time engagement and follow up with email campaigns that leverage knowledge about a customer's past interactions in a retail store, sports stadium and other points-of-interest.

Additional data-driven marketing innovations include real-time mobile app testing, an intuitive dashboard that lets marketers view all their app data on one screen and multi-dimensional portfolio bidding to place search ads across mobile devices.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT